Small-molecule inhibitors of PDI which bind to the CGHC active site may also have potential for improving the efficacy of chemotherapy in melanoma, as inhibition of PDI function proliferates apoptosis (Lovat et al., 2008). The gene discussed is PDIA2; the disease is melanoma.